Sharma Himanshu, Mathur Sandeep Kumar, Purwar Naincy, Sahlot Rahul, Garg Umesh, Sharma Balram
Department of Endocrinology, S.M.S. Medical College and Hospital, Jaipur, Rajasthan, India.
Indian J Endocrinol Metab. 2021 May-Jun;25(3):232-239. doi: 10.4103/ijem.IJEM_55_21. Epub 2021 Oct 26.
Differentiation of growth hormone deficiency (GHD) into various types has been made based on peak stimulated growth hormone levels and other hormone axis involvement. The data regarding how this classification is associated with variation in clinical and biochemical phenotype and how these findings associate with pituitary morphology remains sparse, especially in the Indian population. Therefore, we aimed to ascertain the differences in the pattern of auxological, clinical features including pituitary hypoplasia, and endocrinological profile among patients with severe GHD, partial GHD, and MPHD in the Indian population and to evaluate the association of pituitary height with various clinical and hormonal parameters.
We conducted a cross-sectional study in 100 patients with idiopathic GHD. Patients were grouped into severe GHD, partial GHD, and MPHD to observe the differences in clinical, biochemical, and MRI findings. The pituitary height findings were correlated clinical and biochemical presentation.
MPHD subjects had a significantly higher frequency of breech delivery, neonatal jaundice, neonatal hypoglycemia, and micropenis. A significant difference was observed in the chronological age, bone age retardation (CA-BA), height SDS, weight SDS, peak GH response, IGF-1, IGF-1 SDS, and prevalence of pituitary hypoplasia, pituitary height, and pituitary height SDS among these three groups. In the composite population of GHD, pituitary height SDS was correlated with peak GH, basal IGF-I SDS, and body height SDS.
The clinical and biochemical phenotype differs significantly among the various types of GHD. Pituitary height correlates with these findings and is helpful in further assessment of these patients.
生长激素缺乏症(GHD)已根据刺激后生长激素峰值水平及其他激素轴受累情况分为不同类型。关于这种分类如何与临床和生化表型的变化相关,以及这些发现如何与垂体形态相关的数据仍然稀少,尤其是在印度人群中。因此,我们旨在确定印度人群中重度GHD、部分性GHD和多发性垂体激素缺乏症(MPHD)患者在生长学、临床特征(包括垂体发育不全)和内分泌特征模式上的差异,并评估垂体高度与各种临床和激素参数的相关性。
我们对100例特发性GHD患者进行了一项横断面研究。将患者分为重度GHD、部分性GHD和MPHD组,以观察临床、生化和MRI检查结果的差异。将垂体高度检查结果与临床和生化表现进行相关性分析。
MPHD患者臀位分娩、新生儿黄疸、新生儿低血糖和小阴茎的发生率显著更高。在这三组患者的实际年龄、骨龄延迟(CA - BA)、身高标准差评分(SDS)、体重SDS、生长激素峰值反应、胰岛素样生长因子-1(IGF - 1)、IGF - 1 SDS以及垂体发育不全的患病率、垂体高度和垂体高度SDS方面观察到显著差异。在GHD的综合人群中,垂体高度SDS与生长激素峰值、基础IGF - I SDS和身高SDS相关。
不同类型的GHD在临床和生化表型上存在显著差异。垂体高度与这些发现相关,有助于对这些患者进行进一步评估。